Closing Bell: Nifty 50, Sensex End Lower as Crude Oil Holds Above $89 per barrel

The Nifty 50 opened at 24,575.10 and briefly touched an Intraday high of 24,576.85 before selling pressure pulled the index lower. It touched a low of 24,429.25 and remained largely range-bound around 24,440-24,490 for most of the session as buyers struggled to regain control. The index eventually closed at 24,471.70, down 112.10 points, or 0.46 per cent.

The Sensex also ended lower, falling 388.19 points, or 0.49 per cent, to 78,154.25. The Bank Nifty declined 0.42 per cent, while India VIX fell by 3.65 per cent below the 12 level. Weakness in heavyweight financial stocks and concerns over higher crude oil prices offset gains in IT stocks, strong quarterly earnings and renewed foreign buying.

Brent crude remained above USD 89 per barrel after gaining for four consecutive sessions. Oil prices continued to remain elevated amid uncertainty surrounding a potential agreement between the U.S. and Iran that could help end the conflict and facilitate the reopening of the Strait of Hormuz. Higher crude prices remain a concern for India as the country relies heavily on imports to meet its energy requirements.

Investor flows into equity Mutual Funds also remained strong in July, although preferences shifted towards smaller companies. According to AMFI data, Small-Cap funds attracted net inflows of Rs 7,767.5 crore, while Mid-Cap funds received Rs 6,192 crore. In contrast, Large-Cap funds witnessed net outflows of Rs 1,321.69 crore. Flexi-cap funds also attracted Rs 4,709.08 crore. Overall equity mutual fund inflows stood at Rs 24,697.39 crore, while the mutual fund industry recorded total net inflows of Rs 2.35 lakh crore during the month.

Broader markets ended mixed, with the Nifty Midcap 100 rising 0.02 per cent, while the Nifty Smallcap 100 declined 0.22 per cent. Market performance remained selective as investors focused on individual stocks and quarterly earnings rather than taking broad-based positions.

Pharma stocks led sectoral gains, with the Nifty Pharma index rising 1.35 per cent and snapping a two-session losing streak. Gland Pharma was among the strongest performers, surging 9.64 per cent after reporting its first-quarter earnings. Amara Raja Energy & Mobility also gained 8.08 per cent following its Q1FY27 results.

On the downside, the Nifty FMCG index fell 1.17 per cent, extending its recent weakness. Tata Consumer was among the major laggards in the sector, declining more than 2.5 per cent.

Among the key contributors to the Nifty 50, Eternal added 12.23 points to the index, followed by Dr. Reddy’s Laboratories with a contribution of 6.10 points and Infosys with 5.89 points. On the other hand, Bharti Airtel dragged the index by 18.86 points, while Mahindra & Mahindra and Axis Bank weighed by 11.07 points and 10.97 points, respectively.

Market breadth remained slightly negative on August 11, with more stocks declining than advancing on the NSE. Of the 3,478 stocks traded, 1,487 advanced, 1,867 declined and 124 remained unchanged. A total of 137 stocks touched their 52-week highs, while 57 stocks hit their 52-week lows. Meanwhile, 110 stocks were locked in their Upper Circuits and 97 stocks were locked in Lower Circuits.

Overall, the market remained under pressure as elevated crude oil prices and weakness in key financial stocks outweighed gains in pharma and select heavyweight stocks. Investors are likely to continue tracking crude oil prices, developments around the Strait of Hormuz and U.S.-Iran negotiations, along with the ongoing Q1 earnings season and institutional flows.

Disclaimer: The article is for informational purposes only and not investment advice.